ARTICLE | Distillery Therapeutics
Inflammation
November 9, 2016 8:42 PM UTC
Mouse studies suggest inhibiting ZDHHC21 could help treat systemic inflammatory response syndrome (SIRS). In two mouse models of SIRS, ZDHHC21 knockdown decreased leukocyte adhesion to microvessel wal...
BCIQ Target Profiles